A New Startup Wants to Use Crispr to Diagnose Disease
Genetics pioneer Jennifer Doudna has launched the first commercial Crispr platform for detecting disease-causing DNA.
Genetics pioneer Jennifer Doudna has launched the first commercial Crispr platform for detecting disease-causing DNA.
You have to give Snap credit for giving hardware another try. Its first attempt, the face-camera called Spectacles, fell short of spectacular. But they're back with a new version. The yellow rings around the lenses are gone (the company decided the LED lights were enough of an indication that users are recording video). The new model is more expensive ($150) but it's water-resistant, comes in new colors, and has enhanced imaging capabilities.
Seven years after an earthquake devastated Japan, humans and robots are still trying to clean up Fukushima.
After the ultra-funky i3 and i8, the German automaker is bringing its batteries into the mainstream.